Effect of antenatal betamethasone on prevention of respiratory distress syndrome among neonates with gestational age of 35-36weeks

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT138901193666N1

Enrollment

200

Registered

2010-05-17

Start date

2006-01-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory distress syndrome. Respiratory distress syndrome of newborn

Interventions

Intervention 1: intramuscularly betamethasone. Intervention 2: intramuscularly normal saline.

Prevention

Placebo

intramuscularly betamethasone

intramuscularly normal saline

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: Pregnant women who were high risk for preterm labor in 35-36 weeks of gestation. Exclusion criteria: labor after week 37, Hypertension, Diabetes, Drug abuser, Anomaly in newborn, PROM.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Respiratory distress syndrome. Timepoint: one time. Method of measurement: clinical examination and CT scan.	—

Secondary

Measure	Time frame
Brain hemorrhage. Timepoint: one time. Method of measurement: clinical examination and CT scan.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMajid Mansoury

Kurdistan University of medical sciences

magidmansoori@yahoo.com+98 87 1324 7594

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026